Sampre Nutritions Intrinsic Value
Sampre Nutritions (SAMPRE) median intrinsic value is ₹22.86 from 8 valuation models (range ₹11–₹40), vs current price ₹15.83 — +44.4% upside (Trading Below Calculated Value), margin of safety 30.8%. For current market price and key ratios, visit SAMPRE stock price BSE.
SAMPRE Valuation Methods Summary — DCF, Graham Number & P/E
Sampre Nutritions intrinsic value across 8 models vs current price ₹15.83 — upside/downside and value range per method. Browse Sampre Nutritions financial data for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹19.68 | ₹15.74 - ₹23.62 | +24.3% | EPS: ₹1.64, Sector P/E: 12x |
| Book Value Method | asset | ₹39.58 | ₹35.62 - ₹43.54 | +150.0% | Book Value/Share: ₹43.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹15.24 | ₹13.72 - ₹16.76 | -3.7% | Revenue/Share: ₹19.05, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹22.86 | ₹20.57 - ₹25.15 | +44.4% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹25.87 | ₹20.70 - ₹31.04 | +63.4% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹10.50 | ₹9.45 - ₹11.55 | -33.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹13.51 | ₹12.16 - ₹14.86 | -14.7% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹39.99 | ₹35.99 - ₹43.99 | +152.6% | EPS: ₹1.64, BVPS: ₹43.33 |
SAMPRE Intrinsic Value vs Market Price — All Valuation Models
Sampre Nutritions fair value range ₹11–₹40 vs current market price ₹15.83 across 8 valuation models. Compare with SAMPRE fair value to assess whether the stock is under or overvalued.
SAMPRE Intrinsic Value Analysis — Undervalued or Overvalued?
Sampre Nutritions median intrinsic value ₹22.86, current price ₹15.83 — Trading Below Calculated Value by 44.4%, margin of safety 30.8%.
What is the intrinsic value of SAMPRE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sampre Nutritions (SAMPRE) is ₹22.86 (median value). With the current market price of ₹15.83, this represents a +44.4% variance from our estimated fair value.
The valuation range spans from ₹10.50 to ₹39.99, indicating ₹10.50 - ₹39.99.
Is SAMPRE undervalued or overvalued?
Based on our multi-method analysis, Sampre Nutritions (SAMPRE) appears to be trading below calculated value by approximately 44.4%.
SAMPRE Financial Health — Key Ratios vs Industry Benchmarks
Sampre Nutritions financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.45 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 4.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.35x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
SAMPRE Cash Flow Quality — Operating & Free Cash Flow
Sampre Nutritions operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹-38 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |